CN102716419B - Compound oral liquid for developing intelligence and tonifying kidneys - Google Patents

Compound oral liquid for developing intelligence and tonifying kidneys Download PDF

Info

Publication number
CN102716419B
CN102716419B CN2012102010545A CN201210201054A CN102716419B CN 102716419 B CN102716419 B CN 102716419B CN 2012102010545 A CN2012102010545 A CN 2012102010545A CN 201210201054 A CN201210201054 A CN 201210201054A CN 102716419 B CN102716419 B CN 102716419B
Authority
CN
China
Prior art keywords
parts
fructus
radix
water
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2012102010545A
Other languages
Chinese (zh)
Other versions
CN102716419A (en
Inventor
马瑞钦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bianque Pharmaceutical Co Ltd Hebei Hengxiang Pharmaceutical Group
Original Assignee
Bianque Pharmaceutical Co Ltd Hebei Hengxiang Pharmaceutical Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bianque Pharmaceutical Co Ltd Hebei Hengxiang Pharmaceutical Group filed Critical Bianque Pharmaceutical Co Ltd Hebei Hengxiang Pharmaceutical Group
Priority to CN2012102010545A priority Critical patent/CN102716419B/en
Publication of CN102716419A publication Critical patent/CN102716419A/en
Application granted granted Critical
Publication of CN102716419B publication Critical patent/CN102716419B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a compound oral liquid for developing intelligence and tonifying kidneys. According to the formula, the compound oral liquid comprises the following medicinal raw materials in parts by weight: 14 parts of Morinda officinalis, 7 parts of fructus psoraleae, 9.8 parts of cistanche, 7 parts of alpinia oxyphylla, 1 part of pilos deer horn, 1.4 parts of gecko, 0.4 part of silk moth, 2.8 parts of sheep's penis, 9.8 parts of radix achyranthis bidentatae, 42 parts of teasel root, 4.2 parts of bighead atractylodes rhizome, 14 parts of yam, 42 parts of rhizoma atractylodis, 7 parts of fructus amomi, 14 parts of elecampane, 5.6 parts of fructus aurantii, 7 parts of syzygium aromaticum, 14 parts of liquorice (toasted), 11.2 parts of rehmannia, 11.2 parts of radix asparagi, 7 parts of agilawood, 14 parts of rhizoma cyperi, 9.8 parts of sandalwood, 4.2 parts of pericarpium citri reticulatae viride, 1.4 parts of szechwan Chinaberry fruit, 7 parts of myrrh, 4.2 parts of frankincense, 14 parts of radix curcumae longae, 7 parts of halite and 5.6 parts of chrysanthemum. According to clinical diagnosis, 200 patients with kidney qi deficiency and loss and dysfunction of the spleen in transport take the compound oral liquid twice a day, 10-20ml each time, for three 30-day treatment courses, so that the total effective rate is as high as 70%, and more than 40% of symptoms are improved after one treatment course.

Description

The Fufang Yizhi oral liquor for spleen and kidney
Technical field
The present invention relates to health product technology field, in particular a kind of Fufang Yizhi oral liquor for spleen and kidney.
Background technology
Along with the raising of people's living standard, because kidney qi loss easily appears in work, life, family burden weight, coldness of the body with chills due to dysfunction of the spleen in transportation, pale complexion, shortness of breath and fatigue, spontaneous perspiration, dizziness, abdominal distention is had loose bowels, all kinds of discomforts of soreness of the waist and knees etc., in order to alleviate this situation, occurred a lot of medicines that can improve this type of crowd's health on market, but these medicines mostly belong to headache doctor head, foot is bitterly cured foot and do not had treating both the principal and secondary aspects of a disease, cause that therapeutic effect is not obvious or the effect persistency is poor.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Fufang Yizhi oral liquor for spleen and kidney for the deficiencies in the prior art.
Technical scheme of the present invention is as follows:
A kind of Fufang Yizhi oral liquor for spleen and kidney, raw material prescription weight portion is: 14 parts of Radix Morindae Officinaliss, 7 parts of Fructus Psoraleaes, 9.8 parts of Herba Cistanches, 7 parts of Fructus Alpiniae Oxyphyllaes, 1 part, Cornu Cervi Pantotrichum, 1.4 parts of Geckos, 0.4 part of Bombycis mori, 2.8 parts of Testis Et penis Caprae seu Ovis, 9.8 parts of Radix Achyranthis Bidentataes, 42 parts of Radix Dipsacis, 4.2 parts of the Rhizoma Atractylodis Macrocephalaes, 14 parts of Rhizoma Dioscoreaes, 42 parts of Rhizoma Atractylodis, 7 parts of Fructus Amomis, 14 parts of the Radix Aucklandiae, 5.6 parts of Fructus Aurantiis, 7 parts of Flos Caryophyllis, 14 parts, Radix Glycyrrhizae (processing), 11.2 parts of Radix Rehmanniae, 11.2 parts of Radix Asparagi, 7 parts of Lignum Aquilariae Resinatum, 14 parts of Rhizoma Cyperis, 9.8 parts, Lignum Santali Albi, 4.2 parts, Pericarpium Citri Reticulatae Viride, 1.4 parts of Fructus Toosendans, 7 parts of Myrrhas, 4.2 parts of Olibanums, 14 parts, Rhizoma Curcumae Longae, 7 parts of halites, 5.6 parts of Flos Chrysanthemis.
200 routine clinical diagnosises are the oral oral liquid of the present invention of kidney qi loss, dysfunction of the spleen in transportation patient, one time 10~20 milliliters, 2 times on the one, 30 days courses for the treatment of, after the course for the treatment of, the symptom (coldness of the body with chills more than 40%, pale complexion, shortness of breath and fatigue, spontaneous perspiration, dizziness, abdominal distention is had loose bowels, soreness of the waist and knees) improve, after three courses for the treatment of, total effective rate reaches 70%.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is described in detail.
Radix Morindae Officinalis 14g, Fructus Psoraleae 7g, Herba Cistanches 9.8g, Fructus Alpiniae Oxyphyllae 7g, Cornu Cervi Pantotrichum 1g, Gecko 1.4g, Bombycis mori 0.4g, Testis Et penis Caprae seu Ovis 2.8g, Radix Achyranthis Bidentatae 9.8g, Radix Dipsaci 42g, Rhizoma Atractylodis Macrocephalae 4.2g, Rhizoma Dioscoreae 14g, Rhizoma Atractylodis 42g, Fructus Amomi 7g, Radix Aucklandiae 14g, Fructus Aurantii 5.6g, Flos Caryophylli 7g, Radix Glycyrrhizae (processing) 14g, Radix Rehmanniae 11.2g, Radix Asparagi 11.2g, Lignum Aquilariae Resinatum 7g, Rhizoma Cyperi 14g, Lignum Santali Albi 9.8g, Pericarpium Citri Reticulatae Viride 4.2g, Fructus Toosendan 1.4g, Myrrha 7g, Olibanum 4.2g, Rhizoma Curcumae Longae 14g, halite 7g, Flos Chrysanthemi 5.6g.
Above 30 flavors, the Rhizoma Atractylodis Macrocephalae, Fructus Amomi, the Radix Aucklandiae, Fructus Aurantii, Flos Caryophylli, Lignum Aquilariae Resinatum, Lignum Santali Albi, Pericarpium Citri Reticulatae Viride conventional method are extracted volatile oil, the another device of aqueous solution after distillation is collected, medicinal residues add 2 times of weight of water and decoct 2 hours, filter, aqueous solution after filtrate and distillation merges, and is concentrated into relative density and is about 1.01~1.05 (60 ℃), stand-by.
Fructus Psoraleae, Cornu Cervi Pantotrichum, Gecko, Bombycis mori, Testis Et penis Caprae seu Ovis, Fructus Alpiniae Oxyphyllae are according to the percolation (appendix IO of Chinese Pharmacopoeia version in 2010) under fluid extract and extractum item, make solvent with 80% ethanol, percolation in accordance with the law, collect percolate, reclaim ethanol, medicinal residues add 5 times of amounts of water and decoct 2 hours, filter, filtrate and percolate merge, and are concentrated into relative density and are 1.01~1.05 (60 ℃), stand-by.
All the other ten Six-elements decoct with water three times, add for the first time 5 times of amounts of water, decoct 3 hours, add for the second time 3 times of amounts of water, decoct 2 hours, add for the third time 3 times of amounts of water, decoct 2 hours, collecting decoction, filter, it is 1.01~1.05 (60 ℃) that filtrate is concentrated into relative density, adds ethanol to containing the alcohol amount, reaching 60%, standing 24 hours, filter, filtrate recycling ethanol, and be concentrated into relative density and be 1.03~1.08 (60 ℃), standby.Add Tween 80 2.5g after the volatile oil dilute with water, shake up, merge with above-mentioned medicinal liquid, add Mel 280g, stevioside 0.4g, sorbitol 10g, mix, filter, add water and make into 1000ml, embedding, sterilizing, obtain.
200 routine clinical diagnosises are the oral oral liquid of the present invention of kidney qi loss, dysfunction of the spleen in transportation patient, one time 10~20 milliliters, 2 times on the one, 30 days courses for the treatment of, after the course for the treatment of, the symptom (coldness of the body with chills more than 40%, pale complexion, shortness of breath and fatigue, spontaneous perspiration, dizziness, abdominal distention is had loose bowels, soreness of the waist and knees) improve, after three courses for the treatment of, total effective rate reaches 70%.
Should be understood that, for those of ordinary skills, can be improved according to the above description or convert, and all these improvement and conversion all should belong to the protection domain of claims of the present invention.

Claims (1)

1. a Fufang Yizhi oral liquor for spleen and kidney, is characterized in that, raw material prescription weight portion is: Radix Morindae Officinalis 14g, Fructus Psoraleae 7g, Herba Cistanches 9.8g, Fructus Alpiniae Oxyphyllae 7g, Cornu Cervi Pantotrichum 1g, Gecko 1.4g, Bombycis mori 0.4g, Testis Et penis Caprae seu Ovis 2.8g, Radix Achyranthis Bidentatae 9.8g, Radix Dipsaci 42g, Rhizoma Atractylodis Macrocephalae 4.2g, Rhizoma Dioscoreae 14g, Rhizoma Atractylodis 42g, Fructus Amomi 7g, Radix Aucklandiae 14g, Fructus Aurantii 5.6g, Flos Caryophylli 7g, Radix Glycyrrhizae Preparata 14g, Radix Rehmanniae 11.2g, Radix Asparagi 11.2g, Lignum Aquilariae Resinatum 7g, Rhizoma Cyperi 14g, Lignum Santali Albi 9.8g, Pericarpium Citri Reticulatae Viride 4.2g, Fructus Toosendan 1.4g, Myrrha 7g, Olibanum 4.2g, Rhizoma Curcumae Longae 14g, halite 7g, Flos Chrysanthemi 5.6g;
Above 30 flavors, the Rhizoma Atractylodis Macrocephalae, Fructus Amomi, the Radix Aucklandiae, Fructus Aurantii, Flos Caryophylli, Lignum Aquilariae Resinatum, Lignum Santali Albi, Pericarpium Citri Reticulatae Viride conventional method are extracted volatile oil, the another device of aqueous solution after distillation is collected, medicinal residues add 2 times of weight of water and decoct 2 hours, filter, aqueous solution after filtrate and distillation merges, and 60 ℃ are concentrated into relative density and are 1.01~1.05, stand-by;
Fructus Psoraleae, Cornu Cervi Pantotrichum, Gecko, Bombycis mori, Testis Et penis Caprae seu Ovis, Fructus Alpiniae Oxyphyllae are according to the percolation under Chinese Pharmacopoeia appendix IO fluid extract of version in 2010 and extractum item, make solvent with 80% ethanol, percolation in accordance with the law, collect percolate, reclaim ethanol, medicinal residues add 5 times of amounts of water and decoct 2 hours, filter, filtrate and percolate merge, and 60 ℃ are concentrated into relative density and are 1.01~1.05, stand-by;
All the other ten Six-elements decoct with water three times, add for the first time 5 times of amounts of water, decoct 3 hours, add for the second time 3 times of amounts of water, decoct 2 hours, add for the third time 3 times of amounts of water, decoct 2 hours, collecting decoction, filter, it is 1.01~1.05 that 60 ℃ of filtrates are concentrated into relative density, adds ethanol to containing the alcohol amount, reaching 60%, standing 24 hours, filter, filtrate recycling ethanol, and be concentrated into relative density at 60 ℃ and be 1.03~1.08, standby; Add Tween 80 2.5g after the volatile oil dilute with water, shake up, merge with above-mentioned medicinal liquid, add Mel 280g, stevioside 0.4g, sorbitol 10g, mix, filter, add water and make into 1000ml, embedding, sterilizing, obtain.
CN2012102010545A 2012-06-18 2012-06-18 Compound oral liquid for developing intelligence and tonifying kidneys Active CN102716419B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012102010545A CN102716419B (en) 2012-06-18 2012-06-18 Compound oral liquid for developing intelligence and tonifying kidneys

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012102010545A CN102716419B (en) 2012-06-18 2012-06-18 Compound oral liquid for developing intelligence and tonifying kidneys

Publications (2)

Publication Number Publication Date
CN102716419A CN102716419A (en) 2012-10-10
CN102716419B true CN102716419B (en) 2013-12-04

Family

ID=46942374

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012102010545A Active CN102716419B (en) 2012-06-18 2012-06-18 Compound oral liquid for developing intelligence and tonifying kidneys

Country Status (1)

Country Link
CN (1) CN102716419B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103602562A (en) * 2013-10-08 2014-02-26 陈红洁 Raw materials of health-care wine and preparation method of the health-care wine
CN106198835B (en) * 2016-06-24 2018-06-01 广西灵峰药业有限公司 A kind of quality of production control method of day wingceltis wine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1201683A (en) * 1998-06-16 1998-12-16 靳家富 Medicine for strengthening body and reinforcing intellecture
WO2004050026A2 (en) * 2002-12-02 2004-06-17 Jiafang Chen Compositions and methods for treating prostate cancer
CN1772270A (en) * 2005-10-26 2006-05-17 广西灵峰药业有限公司 Tiantan prepn for treating kidney-yang deficiency diseases and its production process
WO2010035262A2 (en) * 2008-09-25 2010-04-01 Life Biotech Medical Research Ltd Herbal formulations
RU2010102714A (en) * 2007-06-28 2011-08-10 Аскарит Лтд (Il) VEGETABLE COMPOSITIONS FOR TREATING DIABETES AND / OR RELATED CONDITION

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1201683A (en) * 1998-06-16 1998-12-16 靳家富 Medicine for strengthening body and reinforcing intellecture
WO2004050026A2 (en) * 2002-12-02 2004-06-17 Jiafang Chen Compositions and methods for treating prostate cancer
CN1772270A (en) * 2005-10-26 2006-05-17 广西灵峰药业有限公司 Tiantan prepn for treating kidney-yang deficiency diseases and its production process
RU2010102714A (en) * 2007-06-28 2011-08-10 Аскарит Лтд (Il) VEGETABLE COMPOSITIONS FOR TREATING DIABETES AND / OR RELATED CONDITION
WO2010035262A2 (en) * 2008-09-25 2010-04-01 Life Biotech Medical Research Ltd Herbal formulations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
武宇平.补肾化瘀益智汤治疗中风后痴呆症62例.《黑龙江中医学药》.2006,(第6期),第8-9页.
补肾化瘀益智汤治疗中风后痴呆症62例;武宇平;《黑龙江中医学药》;20061231(第6期);全文 *

Also Published As

Publication number Publication date
CN102716419A (en) 2012-10-10

Similar Documents

Publication Publication Date Title
CN104338062A (en) Chinese medicinal preparation for treating stomachache and diarrhea
CN101664482B (en) Externally-applied medicine for treating beriberi and skin pruritus and preparation method thereof
CN101455712B (en) Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method and use thereof
CN101485870A (en) Medicament for promoting digestion and expelling intestinal parasites
CN104027517A (en) Traditional Chinese medicine for treating acute enteritis
CN101007157A (en) Traditional Chinese medicine compound preparation for treating chronic cholecystitis
CN102716419B (en) Compound oral liquid for developing intelligence and tonifying kidneys
CN104001096A (en) Medicine for treating acute gastroenteritis
CN104173546A (en) Traditional Chinese medicine liquid for treating rhinitis
CN105998246A (en) Externally-used traditional Chinese medicine paste for treating painful heel and preparation method thereof
CN103550688B (en) A kind of Chinese medicine composition for the treatment of cardiopalmus
CN104940716A (en) Foot bath composition for treating high blood pressure and preparation method thereof
CN102284053B (en) Foot bathing preparation for treating insomnia
CN104587414A (en) Traditional Chinese medicinal composition for treating headache
CN105250954B (en) A kind of Chinese medicine for treating IBS and preparation method thereof
CN104547530A (en) Chinese medicinal composition for treating diabetes
CN103520684B (en) Traditional Chinese medicine compound for reducing blood sugar
CN101549140B (en) Traditional Chinese medicine composition for treating AIDS and preparation method thereof
CN105327262A (en) Traditional Chinese medicine formula for treating constipation of children and preparing method of traditional Chinese medicine
CN1321677C (en) Chinese herbal medicine for curing hyperthyroidism
CN105796927B (en) A kind of Chinese medicine composition for treating blepharospasm
CN105641414A (en) A traditional Chinese medicine preparation for treating diabetic nephropathy and a preparing method thereof
CN103798472A (en) Healthcare tea and healthcare life-maintaining preparation
CN103006995B (en) Medicine for treating post-dural puncture headache (PDPHA)
CN108210588A (en) A kind of pharmaceutical composition and preparation method with tranquilizing effect

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address

Address after: 054200 Hebei Neiqiu pharmaceutical production base, Xingtai City, Hebei Province

Patentee after: Hebei bianque Pharmaceutical Co., Ltd

Address before: 050000 Hebei province within the pharmaceutical production base

Patentee before: Bianque Pharmaceutical Co., Ltd., Hebei Hengxiang Pharmaceutical Group

CP03 Change of name, title or address